|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 艾瑞芬净>> 市场分析报告 |
艾瑞芬净市场分析报告 |
|
Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Drugs In Development, 2022, provides an ... Coccidioidomycosis - Pipeline Review, H1 2020 Coccidioidomycosis - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coccidioidomycosis - Pipeline Review, H1 2020, provides an overview of the Coccidioidomycosis (Infectious Disease) ... Candidemia – Market Insights, Epidemiology, and Market Forecast—2030 This report can be delivered to the clients within 24 Hours DelveInsight’s ‘Candidemia – Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the Candidemia, historical and forecasted epidemiology as well as ... Coccidioidomycosis (Infectious Disease) - Drugs In Development, 2021 Coccidioidomycosis (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coccidioidomycosis (Infectious Disease) - Drugs In Development, 2021, provides an overview of ... Coccidioidomycosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Coccidioidomycosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coccidioidomycosis - Drugs in Development by Stages ... Non Hormonal Contraceptives Market for Women’s Health by Target Indication (Bacterial Vaginosis, Contraception, Endometriosis, Postmenopausal Osteoporosis, Uterine Fibroids, Vaginitis and Others), Type of Molecule (Biologic and Small Molecule), Purpose of Therapy (Treatment of Disease and Management of Symptoms), Mechanism of Action (Antagonist, Agonist, Inhibitor and Modulator), Route of Administration (intramuscular, intravaginal, intravenous, oral, subcutaneous, topical, transdermal and others), and Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2021-2030 The non hormonal contraceptives market is expected to reach USD 1.8 billion in 2021 and anticipated to grow at a CAGR of 22% during the forecast period 2021-2030. According to the World Health Organization (WHO), around one-third of clinical conditions ... Antifungal Drugs: Technologies and Global Markets Report Scope: The aim of this report is to initially conduct a review of the antifungal drugs currently available; explore the issues facing the use of antifungal drugs; and review some of the latest developments of new and innovative antifungal drugs, ... Coccidioidomycosis - Pipeline Review, H2 2020 Coccidioidomycosis - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coccidioidomycosis - Pipeline Review, H2 2020, provides an overview of the Coccidioidomycosis (Infectious Disease) ... Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aspergillosis - Drugs In Development, 2022, provides an ... Vulvovaginal Candidiasis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Drug Class (Clotrimazole, Nystatin, Fluconazole, Ketoconazole, Terbinafine, Terconazole, Others), By Route of Administration (Oral, Intravenous, Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition, 2020-2030F ... . For instance, the U.S. FDA approved ibrexafungerp, a novel triterpenoid antifungal agent, for ... Anti-Fungal Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Mucormycosis, Dermatophytosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Topical, Oral, Parenteral, Others), By End User (Homecare, Hospitals, Clinics, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region and Competition, 2020-2030F ... RVVC while continuing the development of ibrexafungerp, which is currently in phase III clinical ... Global ?-1,3 Glucan Market Growth 2025-2031 ... widespread attention. The new drugs ibrexafungerp and rezafungin United States market ... Fungal Lung Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major fungal lung diseases markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The fungal lung diseases market has been comprehensively analyzed in IMARC's new report titled "Fungal Lung Diseases Market: Epidemiology, Industry Trends, ... Invasive Candidiasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major invasive candidiasis markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.12% during 2024-2034. The invasive candidiasis market ... Vaginitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major vaginitis markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 3.49% during 2024-2034. The vaginitis market has been ... Vulvovaginal Candidiasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major vulvovaginal candidiasis markets reached a value of US$ 734.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,058.2 Million by 2034, exhibiting a growth rate (CAGR) of 3.37% during 2024-2034. The vulvovaginal ... Global Fungal ?-glucan Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031 ... widespread attention. The new drugs ibrexafungerp and rezafungin This report is a detailed ... Global ?-1,3 Glucan Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031 ... widespread attention. The new drugs ibrexafungerp and rezafungin This report is a detailed ... Global Fungal ?-glucan Market Growth 2025-2031 ... widespread attention. The new drugs ibrexafungerp and rezafungin United States market ... |